Warning letter
Bausch & Lomb: warning letter of Jul 17, 2002
FDA warning letter UCM145021 · Atlanta District Office
Key facts
| Reference number | UCM145021 |
|---|---|
| Company | Bausch & Lomb |
| Subject | Quality System Regulation/Adulterated |
| Issue date | Jul 17, 2002 |
| Posted date | Jul 17, 2002 |
| Issuing office | Atlanta District Office |
| Product type | Unknown |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Greenville |
| Inspection ZIP | 29615-5749 |
| Inspection start date | May 20, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: